enVVeno Medical (NVNO) Gross Margin (2017 - 2019)

enVVeno Medical (NVNO) posted quarterly Gross Margin of 100.0% for Q1 2019, little changed quarter-over-quarter from 100.0% in Q4 2018.

enVVeno Medical (NVNO) Gross Margin (2017 - 2019) Analysis & Trends

enVVeno Medical's Gross Margin history runs 3 years deep, the most recent figure standing at 100.0% for Q1 2019.

In Q1 2019, Gross Margin changed N/A year-over-year to 100.0%; the TTM figure through Mar 2019 stood at 100.0% (changed N/A YoY), while the FY2018 annual figure was 100.0%, up 9942.0% from the prior year.
Gross Margin for Q1 2019 stood at 100.0%, roughly flat from 100.0% in the prior quarter.
The five-year high for Gross Margin was 100.0% in Q2 2017, with the low at 376.83% in Q3 2017.
The 3-year median for Gross Margin is 100.0% (2017), against an average of 23.89%.
Peak annual rise in Gross Margin reached 47683 bps in 2018, while the deepest fall reached 0 bps in 2018.
enVVeno Medical's Gross Margin stood at 44.05% in 2017, then soared by 127 bps to 100.0% in 2018, then changed by 0 bps to 100.0% in 2019.
Business Quant data shows NVNO's Gross Margin at 100.0% in Q1 2019, 100.0% in Q4 2018, and 100.0% in Q3 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Abbott Laboratories	200.19 Bn	194.59 Bn	7.27 Bn	57.71%
2	Stryker	129.95 Bn	126.47 Bn	4.50 Bn	68.27%
3	Medtronic	120.06 Bn	110.84 Bn	6.41 Bn	65.35%
4	Boston Scientific	74.14 Bn	73.60 Bn	3.85 Bn	70.71%
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn	77.46%
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn	63.44%
7	GE HealthCare Technologies	34.20 Bn	32.10 Bn	2.18 Bn	41.17%
8	Koninklijke Philips	26.46 Bn	23.13 Bn	4.55 Bn	47.38%
9	Steris	23.25 Bn	22.77 Bn	684.20 Mn	45.84%
10	enVVeno Medical	7.05 Mn	7.05 Mn	-	-

Download Data